Label (2nd Panel)
Drosera Pellet
Product Images NDC 0220-1796
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Drosera (NDC 0220-1796). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Boiron, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Label (3rd Panel)
This is a drug fact sheet for a product with an active ingredient mentioned on the front label. The product contains 0.443mg of the active ingredient per pellet, and the uses are mentioned on the front panel. The warnings instruct the user to consult a doctor if symptoms persist for more than 3 days or worsen, and to consult a healthcare professional before use if pregnant or breastfeeding. The product should be kept out of reach of children. The directions advise dissolving five pellets under the tongue three times a day until symptoms are relieved or as directed by a doctor. If the seal of the pellet dispenser is broken, the pellets should not be used.*
Label (Drosera30c)
The text is a description of a homeopathic cough medicine called Drosera. It is manufactured in France by Boiron and contains approximately 0 pellets. The medicine is intended for the treatment of spasmodic dry cough that worsens at night and by heat. The packaging includes important information on usage, lot number and expiry date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
